Suzanne Partridge MD Board Certified
Board Certified in Medical Oncology, Hematology and Internal Medicine
Join to View Full Profile
3301 Mercy Health BlvdCincinnati, OH 45211
Phone+1 513-751-2273
Fax+1 513-574-7062
Dr. Partridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2008
University Hospital The2005- University of Cincinnati Medical Center/College of MedicineInternship, Internal Medicine, 2002 - 2003
The University of Toledo College of MedicineClass of 2002
Certifications & Licensure
OH State Medical License 2002 - 2026
IN State Medical License 2011 - 2023
MO State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Publications & Presentations
PubMed
- 9 citationsThromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.Julianna V. F. Roddy, Suzanne M. Partridge, Michelle L. Rockey, Jane M. Pruemer, Jeff J. Guo
American Journal of Clinical Oncology. 2010-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
